The usefulness of acetyl-l-carnitine in polyneuropathy treatment and prevention was assessed by several studies [70,71,72,73,74,75,76,77] (Table 2)
doi:10.1001/jama.2023.2438 6
Most patients experience peak bloating in weeks 13 of treatment or after dose increases
41 As discussed above, mitochondrial dysfunction (mitochondrial bioenergetics, calcium buffering) and mitochondrial quality control systems (mitochondrial dynamics, mitophagy, mitochondrial biogenesis) may be involved in the pathological mechanisms of diabetes-related NDs
This narrative review aims to bridge the gap between evidence and clinical practice regarding the use of GLP-1 RAs in the perioperative period by critically evaluating changing clinical recommendations to inform a balance between the risks of aspiration and the potential surgical benefits
[3] [4] Eligibility for weight loss medication in the UK depends on the specific medicine and is determined by NICE guidance and individual clinical assessment: Orlistat is generally considered for adults with a BMI of 30 kg/m or above, or a BMI of 28 kg/m or above in the presence of weight-related comorbidities such as type 2 diabetes or hypertension
